Publication | Closed Access

Utilization of biologic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis and cancer

Rheumatoid DisorderRheumatologyAnti-inflammatoryAutoimmune DiseaseMedicineRheumatic DiseasesImmunologyBiological TherapyInflammatory Rheumatic DiseasePharmacotherapyImmunotherapyPharmacologyRheumatoid Arthritis